These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 8917180

  • 1. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism.
    Neumann DR, Esselstyn CB, Maclntyre WJ, Go RT, Obuchowski NA, Chen EQ, Licata AA.
    J Nucl Med; 1996 Nov; 37(11):1809-15. PubMed ID: 8917180
    [Abstract] [Full Text] [Related]

  • 2. Primary hyperparathyroidism: preoperative parathyroid imaging with regional body FDG PET.
    Neumann DR, Esselstyn CB, MacIntyre WJ, Chen EQ, Go RT, Kohse LM, Licata AA.
    Radiology; 1994 Aug; 192(2):509-12. PubMed ID: 8029424
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regional body FDG-PET in postoperative recurrent hyperparathyroidism.
    Neumann DR, Esselstyn CB, MacIntyre WJ, Chen EQ, Go RT, Licata AA.
    J Comput Assist Tomogr; 1997 Aug; 21(1):25-8. PubMed ID: 9022764
    [Abstract] [Full Text] [Related]

  • 5. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.
    Casas AT, Burke GJ, Sathyanarayana, Mansberger AR, Wei JP.
    Am J Surg; 1993 Oct; 166(4):369-73. PubMed ID: 8214295
    [Abstract] [Full Text] [Related]

  • 6. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
    Neumann DR, Esselstyn CB, Go RT, Wong CO, Rice TW, Obuchowski NA.
    AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
    Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, Dackiw AP, Tufano RP, Zeiger MA, Ziessman HA.
    J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
    [Abstract] [Full Text] [Related]

  • 11. The complementary roles of fast spin-echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands.
    Lee VS, Spritzer CE, Coleman RE, Wilkinson RH, Coogan AC, Leight GS.
    AJR Am J Roentgenol; 1996 Dec; 167(6):1555-62. PubMed ID: 8956597
    [Abstract] [Full Text] [Related]

  • 12. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism.
    Melon P, Luxen A, Hamoir E, Meurisse M.
    Eur J Nucl Med; 1995 Jun; 22(6):556-8. PubMed ID: 7556303
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR, Esselstyn CB, Madera A, Wong CO, Lieber M.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.
    Casas AT, Burke GJ, Mansberger AR, Wei JP.
    Am Surg; 1994 Jan; 60(1):12-6; discussion 16-7. PubMed ID: 8273968
    [Abstract] [Full Text] [Related]

  • 17. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism.
    Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF.
    Clin Radiol; 2010 Apr; 65(4):278-87. PubMed ID: 20338394
    [Abstract] [Full Text] [Related]

  • 18. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
    Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, Ochoa BB, Moxley DM, Erwin WD, Podoloff DA.
    J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
    [Abstract] [Full Text] [Related]

  • 19. Preliminary experience with double-phase SPECT using Tc-99m sestamibi in patients with hyperparathyroidism.
    Neumann DR, Esselstyn CB, Kim EY, Go RT, Obuchowski NA, Rice TW.
    Clin Nucl Med; 1997 Apr; 22(4):217-21. PubMed ID: 9099475
    [Abstract] [Full Text] [Related]

  • 20. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
    Taillefer R, Boucher Y, Potvin C, Lambert R.
    J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.